Company Valuation of a Medical Device Startup

Company valuation for many medical device startups is smaller than traditional start-up companies. Many startups are venture-backed or backed by private equity or other financial investors.

Unlike venture-backed start-ups, they are not looking to be acquired but are focused on growing and realizing their value to current and potential customers. Consequently, their business model tends to place a premium on rapid growth and profitability.

Most startups in the medical device space are reasonably young and in the process of scaling their business. They will not likely require significant short-term funding to achieve scale. Thus, they tend to be less capital-intensive than typical private-equity or venture-backed firms.

Below, we are talking about various business valuation methods and approaches available for valuing medical device startups, their requirements, and their consideration. We’ll go over the key steps in determining the value of a medical device company and provide some helpful tips for startups in this space.

Company Valuation of Startup Enterprises

startup valuation

Many startups in the medical device arena are private companies, so company valuation analysis is challenging. However, based on our experience as an equity investors in more than 10 companies in the space, We’ve identified the following points that help in determining the value of a medical device company. Typically, a medical device startup will generate about one-third of its revenue in the form of recurring and often very high-margin maintenance contracts.

These contracts are typically for shorter duration, though they typically have a lower upfront cost as well as lower maintenance costs. Typically, a medical device startup business model will generate about one-third of its revenue in the form of recurring and often very high-margin maintenance contracts.

Medical device companies tend to be fairly small, with a market capitalization of between $50 million to $1 billion. The majority of start-ups in the medical device industry are under 10 years old and have grown their annual revenue by over 50 percent in the past three years. In addition, most early-stage firms expect to achieve rapid revenue growth during their first three years and double-digit revenue growth after the first five years.

So, it’s not uncommon for a company to have 3X to 5X the revenue of its closest competitor, as well as significant gross margins. Some high-growth medical device start-ups have recently been valued at over $100 million. (Says Economic times news).

What are the Main Business Valuation Methods?

startup valuation

The ideal business valuation methods for a medical device business model vary by country and industry. The most common methods used in India for valuing a medical device start-up include the book-value method, using the company’s balance sheet, followed by peer comparison of a start-up company to its peers (such as Varian Medical Systems (NYSE: VAR) and Stryker (NYSE: SYK), sum-of-the-parts (SOTP) method, and more.

We can consider the book-value method for the business valuation process. Some of the advantages of using the book-value business valuation methods for the valuation of a medical device start-up include: Preparing a business valuation report, Provides a comprehensive view of a company’s assets, cash flow, and liabilities. It is easy to construct an in-depth balance sheet and income statement that allows for comparison across industries and for the company valuation with a valuation professional. Only a company valuation professional can select the right business valuation methods.

Many medical device companies don’t have good expectations for company valuation. The reasons are many, also some small business owner does not expect their businesses to be very profitable. Many medical device companies are selling technology and services to the medical and health care industries.

Not surprisingly, these organizations are not in a position to offer big guaranteed discounts to start-up companies for the use of their technologies. Moreover, if the cost savings for a technology company selling services to hospitals and clinics is significant enough, then traditional industry players.

Most company valuation can be grouped under the most common core valuation method – a discounted cash flow (DCF) or DCF valuation company valuation method. other valuation methods may also be employed such as earnings multiples, trading multiples, comparable companies multiple method, new asset value method, or other fundamentals.

However, all the valuation methods fall under three main approaches such are Asset Approach, Income Approach, Asset Approach.

Asset Approach

A typical asset approach suggests creating a new company on a new set of facts. For example, a new company can be created by splitting a start-up into two or three start-up companies based on similar technologies. Another method is to compare a start-up company to a new set of comparable. For example, a company could be compared to a new start-up company that became a big success after acquiring its target. You May Also Want To Watch: Income Approaches for medical device start-ups Income approach is the most common valuation methodology for medical device startups. The rationale behind this approach is that a start-up that has yet to be monetized should have no revenue to report.

Income Approach

The income approach refers to the theory that a company’s value can be derived from the amount of income generated from the business activities of the company. The type of methods employed depends on whether the company is profitable or loss-making. Profitable companies generally use the cash flow approach while loss-making companies use the net income approach.

Market Approach

When estimating the potential market size for medical devices, you can consider both the most recent sales data and valuing historical sales. Whether to use historical sales as a market-sensitivity indicator is debatable, but most successful medical device companies have the ability to generate significant revenue from the product and this is the reason investors choose to evaluate the historic performance. Market sizing is likely to be the most time-consuming process for a medical device start-up. The long-term cost of a medical device is typically in the range of USD 1.5 to 2 per patient, and the current average cost of treatment for this disease is in the range of USD 12,000 to 25,000.

Startup Valuation Methods – No Nonsense guide to startup Valuation

Valuation of Medical Device Start-ups

medical device startup valuation

Valuing a medical device start-up is a delicate exercise. For start-ups, we would also want to discount the potential value from disruption to the incumbents in the market. However, it is very difficult to make the case that an incumbent should not, at a minimum, be taken seriously as it is for every other technology business.

We view the potential for new entrants to disrupt an incumbent as a real risk, regardless of whether they can realistically realize the value of the opportunity. Based on conversations with industry experts, we have used three valuation frameworks for the medical device industry. They are appropriate for the various stages of a medical device startup’s life.

Let’s take a closer look at what you need to know about how to value a medical device startup enterprise.

1. A good starting point is to evaluate the expectations of the purchaser(s) of the medical device.

2.The number of possible stakeholders for a medical device start-up is typically quite large. These range from general patients and insurance providers to professional medical users. In addition, most medical devices have external regulatory and payer entanglements.

There is a common thread among all parties involved with medical devices: the industry is often valued by looking at the expected payback period of investment. Expectations for a medical device start-up enterprise usually range between three and six years, with the tailoring of this estimate to the market or product.

Valuation Considerations

Considering what it will cost a medical device start-up to reach the target customers it currently has or might want, if it expands its customer base or buys/upgrades other products in its portfolio, it will make up the bulk of a medical device start-up valuation. The current market in medical devices is roughly $30 billion per year.

This figure is only expected to grow, driven by population growth and continued technological advancements. With the median annual income for a U.S. household now at around $52,000, these industries typically have a relatively low market capitalization, with the exceptions of high-growth companies, and those areas of innovation that are not too mainstream.

All businesses that have revenues, profit, or earnings face market forces to justify the level of ownership interest and control of the entity. This valuation is an important part of the business assessment as it is an initial evaluation of the company. The factors considered when valuing a medical device start-up include the following: Market Capacity Challenges, Capitalization Valuation Investors and business owners rely on the valuation to estimate the financial situation, overall value, and control of a company.

The valuation is a reliable measure of the interest or control by existing and potential investors, the condition of the business, and the business owner’s desire for a sale or ownership change.

Final Thoughts

Based on industry sources, and market research, we find Medical Device start-ups generally are not valued similarly to common equities or other equity capital markets. However, the business valuation methods could be the same as those used for other startups.

Given the concentration of innovation risk, the emerging nature of the business model and the relative newness of the industry, we view investment in Medical Device start-ups as a high risk, high reward proposition. There are ample potential fund sizes available for Medical Device companies, and the fees offered are quite attractive.